Arylsulphonyl hydroxamic acids: Potent and selective matrix metalloproteinase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 11, Issue 11, 2001, Pages 1465-1468

  Baxter, Andrew D ^a   Bhogal, Ranjev ^a   Bird, John ^a   Keily, John F ^a   Manallack, David T ^a   Montana, John G ^a   Owen, David A ^a   Pitt, William R ^a   Watson, Robert J ^a   Wills, Ruth E ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXAMIC ACID DERIVATIVE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; REBIMASTAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CANCER; CHEMICAL REACTION; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; FEMALE; IN VIVO STUDY; NONHUMAN; RAT; REACTION ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASES; MELANOMA, EXPERIMENTAL; MICE;

EID: 0035806101     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(01)00259-1     Document Type: Article

References (14)